ライフサイエンスコーパス: urinary incontinence

1 en inducing nerve damage to create models of urinary incontinence.

2 organ prolapse are at risk for postoperative urinary incontinence.

3 n the frequency of daily episodes of urgency urinary incontinence.

4 omboembolic events, gallbladder disease, and urinary incontinence.

5 benefits of preventing postoperative stress urinary incontinence.

6 of complications of sling surgery for stress urinary incontinence.

7 tectomy would result in 1 additional case of urinary incontinence.

8 for the treatment of mild-to-moderate stress urinary incontinence.

9 which NA reuptake inhibitors improve stress urinary incontinence.

10 instay for treating postprostatectomy stress urinary incontinence.

11 ls per week, multiple chronic illnesses, and urinary incontinence.

12 ve intervention for all patients with stress urinary incontinence.

13 r watery stools, poor self-rated health, and urinary incontinence.

14 of operative procedure for women with stress urinary incontinence.

15 ogen resulted in inconsistent improvement of urinary incontinence.

16 have a high success rate for treating stress urinary incontinence.

17 nue drug therapy and maintain improvement in urinary incontinence.

18 reporting on surgical management for stress urinary incontinence.

19 ice in patients with neurogenic bladders and urinary incontinence.

20 Duloxetine improved but did not resolve urinary incontinence.

21 Adrenergic drugs did not resolve or improve urinary incontinence.

22 Electrical stimulation failed to resolve urinary incontinence.

23 condary stress urinary incontinence and urge urinary incontinence.

24 e front-line therapeutic modality for stress urinary incontinence.

25 sodes per 24 hours), with or without urgency urinary incontinence.

26 n a woman's bladder and vagina, resulting in urinary incontinence.

27 ult women, include pelvic organ prolapse and urinary incontinence.

28 iological slings for the treatment of stress urinary incontinence.

29 s been used to manage stress, urge and mixed urinary incontinence.

30 be discussed with patients with intractable urinary incontinence.

31 er alternatives in difficult cases of stress urinary incontinence.

32 ing, or other medical conditions can lead to urinary incontinence.

33 ews the data on its use in the management of urinary incontinence.

34 involving 381 women with refractory urgency urinary incontinence.

35 atment of choice in the management of stress urinary incontinence.

36 etry) prior to surgical treatment for stress urinary incontinence.

37 n controlling refractory episodes of urgency urinary incontinence.

38 preoperative evaluation of women with stress urinary incontinence.

39 est outcome of surgical treatment for stress urinary incontinence.

40 much less health care economic data than for urinary incontinence.

41 hological symptoms in persons with fecal and urinary incontinence.

42 been no meaningful research on prevention of urinary incontinence.

43 dysfunction leads to overactive bladder and urinary incontinence.

44 was the greatest risk factor for developing urinary incontinence.

45 ween 12% and 55% for having ever experienced urinary incontinence.

46 drugs are effective in the treatment of urge urinary incontinence.

47 bit urinary frequency, urgency, and at times urinary incontinence.

48 e evidence regarding the efficacy of PTNS in urinary incontinence.

49 ogynecologic surgery, urinary retention, and urinary incontinence.

50 archical fashion which minimizes the risk of urinary incontinence.

51 in the treatment of the components of mixed urinary incontinence.

52 nd therapeutic options for women affected by urinary incontinence.

53 durethral-sling surgery in women with stress urinary incontinence.

54 se of medication or indwelling catheters for urinary incontinence.

55 xperienced significant reductions in urgency urinary incontinence (-0.88 vs -0.31, P=.005), urgency e

56 ation (23.3 [13.7] vs 24.6 [14.0]; P = .36), urinary incontinence (10.6 [17.7] vs 9.7 [15.8]; P = .99

57 olism (11 more cases [95% CI, 3 to 22]), and urinary incontinence (1261 more cases [95% CI, 880 to 16

58 isease (33 more per 10 000 woman-years), and urinary incontinence (1271 more per 10 000 woman-years).

59 d cortical atrophy (P = .01), nonobstructive urinary incontinence (18.5% vs 3.9%; P = .04), and synco

60 s 10 to 12 points for sexual function, 6 for urinary incontinence, 5 for urinary irritative symptoms,

61 ethral strictures (17.8% vs 9.5%), and total urinary incontinence (6.5% vs 2.8%).

62 mentia (22 more per 10 000 woman-years), and urinary incontinence (872 more per 10 000 woman-years).

63 ]), stroke (9 more cases [95% CI, 2 to 19]), urinary incontinence (876 more cases [95% CI, 606 to 116

64 of women (95% CI, 13.2%-18.2%) experiencing urinary incontinence, 9.0% of women (95% CI, 7.3%-10.7%)

65 Mixed urinary incontinence, a condition of both stress and urg

66 , 1.28; 95% CI, 1.08 to 1.52; P = .005), and urinary incontinence (adjusted OR, 1.42; 95% CI, 1.20 to

67 sor overactivity are the major categories of urinary incontinence affecting men.

68 Male urinary incontinence affects a significant number of eld

69 Stress urinary incontinence after prostate cancer treatment is

70 Urinary incontinence after treatment for prostate cancer

71 At 12 months, urinary incontinence (allowing for subsequent treatment

72 associated with better resident outcomes of urinary incontinence among organizational factors.

73 e social consequences of the surgery such as urinary incontinence, anastomotic contracture, erectile

74 Rates of urinary incontinence and anastomotic stricture are accep

75 re rate for patients with predominant stress urinary incontinence and can safely be placed at the tim

76 The management of children with urinary incontinence and dysfunctional voiding problems

77 Urinary incontinence and erectile and sexual dysfunction

78 ic mortality rates, and improved recovery of urinary incontinence and erectile function after open ra

79 most efficacious treatment for severe stress urinary incontinence and for radiated patients.

80 uestionnaires, were participants' reports of urinary incontinence and incremental cost per quality-ad

81 ence-based assessment and management of both urinary incontinence and its associated conditions.

82 e use of conservative management in men with urinary incontinence and other LUTS.

83 g-term complications from mesh use in stress urinary incontinence and pelvic organ prolapse repair ar

84 aised about the safety of surgery for stress urinary incontinence and pelvic organ prolapse using tra

85 advances for the treatment of female stress urinary incontinence and pelvic organ prolapse.

86 to use synthetic grafts in repair of stress urinary incontinence and pelvic organ prolapse.

87 with the use of vaginal mesh for both stress urinary incontinence and POP.

88 Two months after surgery, he had mild stress urinary incontinence and PSA of < 0.1 ng/mL.

89 thral slings used in the treatment of stress urinary incontinence and the management of these complic

90 main types of incontinence in women, stress urinary incontinence and urge urinary incontinence, can

91 l sacrocolpopexy can reduce secondary stress urinary incontinence and urge urinary incontinence.

92 erations have been developed to treat stress urinary incontinence and yet, at present, there is no co

93 as concerned about the potential for greater urinary incontinence and/or urinary irritation associate

94 obstruction and irritation, 9.7 to 10.5 for urinary incontinence, and 5.7 to 6.1 for bowel problems.

95 unction, urinary obstruction and irritation, urinary incontinence, and bowel problems-each scored fro

96 imately three times the rate of diagnosis of urinary incontinence, and more than four times the rate

97 slowing, balance difficulties with falls and urinary incontinence, and one was wheelchair bound.

98 d proportion of fistula recurrence, residual urinary incontinence, and pregnancy after successful fis

99 d basic sociodemographics, cognitive status, urinary incontinence, and self-reported ability to do ac

100 was due to claims indicative of urethritis, urinary incontinence, and/or obstruction.

101 Women with urge urinary incontinence are commonly treated with antimusca

102 and minimally-invasive therapies for stress urinary incontinence are expanding.

103 Pharmacologic clinical trials for urinary incontinence are no different than pharmacologic

104 Importance: Women with refractory urgency urinary incontinence are treated with sacral neuromodula

105 ures, which required a negative pad test, no urinary incontinence (as recorded in a 3-day diary), a n

106 In trial 2, the difference in the rate of urinary incontinence at 12 months (126 [65%] of 194) fro

107 e intervention group in trial 1, the rate of urinary incontinence at 12 months (148 [76%] of 196) was

108 to treat with a sling to prevent one case of urinary incontinence at 12 months was 6.3.

109 prolapse surgery resulted in a lower rate of urinary incontinence at 3 and 12 months but higher rates

110 Prevention of postoperative stress urinary incontinence at the time of prolapse repair is c

111 it is less clear that the severity of stress urinary incontinence, based on either abdominal leak poi

112 Thus, it is important that urinary incontinence be amenable to improving conditions

113 ntinence in men compared with women, despite urinary incontinence being relatively common and burdens

114 aged >/=65 years), gallbladder disease, and urinary incontinence; benefits included decreased hip fr

115 our domains (urinary irritative-obstructive, urinary incontinence, bowel, and sexual), significant HR

116 ikely to have complete resolution of urgency urinary incontinence but had higher rates of transient u

117 n established and modifiable risk factor for urinary incontinence, but conclusive evidence for a bene

118 onabotulinumtoxinA are used to treat urgency urinary incontinence, but data directly comparing the tw

119 nce exists concerning its efficacy in stress urinary incontinence, but its benefit to women with mixe

120 increased public awareness of the problem of urinary incontinence, but many new products are being in

121 ine exerts only modest relief of male stress urinary incontinence, but may be recommended in some pat

122 performed in women before surgery for stress urinary incontinence, but there is no good evidence that

123 inence with weight loss, for treating stress urinary incontinence by performing anti-incontinence pro

124 at patients with more severe forms of stress urinary incontinence by urodynamic testing fare more poo

125 The term intractable urinary incontinence can be applied to urinary incontine

126 Research in the field of surgery for urinary incontinence can be facilitated by development o

127 been identified, and studies have shown that urinary incontinence can have substantial negative impac

128 women, stress urinary incontinence and urge urinary incontinence, can be evaluated by history and si

129 re the organizational factors that influence urinary incontinence care quality controlling for patien

130 mine the impact of organizational factors on urinary incontinence care quality defined as the improve

131 emorrhage (p=0.014), dysphagia (p=0.003) and urinary incontinence/catheterisation (p=0.000) were at h

132 ms such as mood changes, sleep disturbances, urinary incontinence, cognitive changes, somatic complai

133 Oxybutynin or tolterodine resolved urinary incontinence compared with placebo (pooled risk

134 al hormone administration increased rates of urinary incontinence compared with placebo in most RCTs

135 r muscle training alone resolved or improved urinary incontinence compared with regular care, althoug

136 the pharmacological treatment of male stress urinary incontinence, confirming that duloxetine had a m

137 al tape is the foremost technique for stress urinary incontinence correction, many of the newer modal

138 Subjective stress urinary incontinence 'cure/improvement' rates after surg

139 Clinicians should prioritize urinary incontinence detection, identify and treat modif

140 The Questionnaire for Urinary Incontinence Diagnosis, the Psychological Genera

141 e from baseline mean number of daily urgency urinary incontinence episodes over 6 months, was measure

142 loss reduced the frequency of self-reported urinary-incontinence episodes among overweight and obese

143 overweight and obese women with at least 10 urinary-incontinence episodes per week to an intensive 6

144 we recorded 24 cases of post-repair residual urinary incontinence, equivalent to a cumulative inciden

145 ics in the preoperative assessment of stress urinary incontinence, especially at this time of rapid c

146 cantly higher prevalence of hearing trouble, urinary incontinence, falls, depression, and osteoporosi

147 Pelvic floor disorders (urinary incontinence, fecal incontinence, and pelvic org

148 systemic or pulmonary arterial hypertension, urinary incontinence, gastrointestinal and neuropsychiat

149 he recommendations made by the Female Stress Urinary Incontinence Guidelines Panel summary report.

150 dies are getting closer to the female stress urinary incontinence guidelines.

151 A man in his 30s with paraparesis and urinary incontinence had a long-segment thoracic lesion

152 The use of slings to treat female stress urinary incontinence has had resurgence with new surgica

153 asive techniques emerge, treatment of stress urinary incontinence has increased over time.

154 re known to be effective in stress and mixed urinary incontinence, has demonstrated that this therapy

155 As treatment strategies for stress urinary incontinence have developed over the last severa

156 new drug treatments and surgical devices for urinary incontinence have had mixed results; direct-to-c

157 < .0001) domains among BT patients, whereas urinary incontinence HRQOL worsened for both the BT (P =

158 s outcomes in the treatment of female stress urinary incontinence illustrate many of the current prob

159 The odds of urinary incontinence improvement from admission in urban

160 n 96%, falls in 76%, pyramidal signs in 54%, urinary incontinence in 50% and dementia in 39%.Visual h

161 ctors associated with prevalent and incident urinary incontinence in a diverse cohort of midlife wome

162 e frequently used in the treatment of stress urinary incontinence in a variety of patients.

163 that focused on the etiology or treatment of urinary incontinence in adult women.

164 nsider when choosing an operation for stress urinary incontinence in an individual patient.

165 sed successfully for the treatment of stress urinary incontinence in both male and female patients.

166 dverse events of these procedures for stress urinary incontinence in England over 8 years.

167 ocedure for contemporary treatment of stress urinary incontinence in individual patients.

168 Recent research has focused less on urinary incontinence in men compared with women, despite

169 re are excellent options for managing stress urinary incontinence in men, and recent data have allowe

170 y updated information on the epidemiology of urinary incontinence in men.

171 wo decades, relatively little is known about urinary incontinence in non-White women or in men.

172 studies demonstrate that surgery for stress urinary incontinence in older women improves symptoms, a

173 The clinical management of urinary incontinence in people with dementia with medica

174 s may be pragmatically appropriate to manage urinary incontinence in select patients.

175 often describe the impact of both fecal and urinary incontinence in terms of shame and embarrassment

176 -years at risk (95% confidence interval) for urinary incontinence in the dementia cohort, among men a

177 lation has been approved for use in treating urinary incontinence in the United States since 1997, an

178 pproach to the surgical management of stress urinary incontinence in women and marked a resurgence in

179 dence base for surgical management of stress urinary incontinence in women between July 2006 and Dece

180 Urinary incontinence in women is a common problem that a

181 Urinary incontinence in women is an important public hea

182 rgan prolapse decreases postoperative stress urinary incontinence in women without preoperative sympt

183 uscle training and bladder training resolved urinary incontinence in women.

184 s on the evaluation and management of stress urinary incontinence in women.

185 cal intervention for the treatment of stress urinary incontinence in women.

186 ave also examined risk factors and impact of urinary incontinence, including lifestyle, comorbidities

187 For women with stress urinary incontinence, initial midurethral-sling surgery,

188 Urinary incontinence is a common clinical problem, parti

189 Urinary incontinence is a common geriatric syndrome that

190 Urinary incontinence is a socially disabling condition w

191 Conservative treatment for urinary incontinence is an effective intervention and ha

192 Urinary incontinence is an important condition affecting

193 Urinary incontinence is common immediately after prostat

194 Urinary incontinence is common in women, although few se

195 Urinary incontinence is common in women, but is under-re

196 Urinary incontinence is common in women.

197 The treatment of male urinary incontinence is constantly evolving, with recent

198 y evidence for treatment of women with mixed urinary incontinence is lacking, as are clear diagnostic

199 ce for a beneficial effect of weight loss on urinary incontinence is lacking.

200 Further research into the cause of stress urinary incontinence is necessary.

201 Pharmacologic research for urinary incontinence is now entering an exciting time be

202 Male urinary incontinence is often seen following prostate su

203 exciting area in pharmacologic treatment of urinary incontinence is the method of drug delivery.

204 tinence, a condition of both stress and urge urinary incontinence, is prevalent in 20% to 36% of wome

205 , or both (LR range, 2.2-2.8), and new-onset urinary incontinence (LR, 4.6; 95% CI, 2.8-7.6) increase

206 Patients with stress urinary incontinence mainly suffer from malfunction of t

207 A decrease in urinary incontinence may be another benefit among the ex

208 hat a familial predisposition towards stress urinary incontinence may exist.

209 ry outcomes were success in terms of overall urinary-incontinence measures, which required a negative

210 advocated as first-line treatment for stress urinary incontinence; midurethral-sling surgery is gener

211 fter vaginal surgery for prolapse and stress urinary incontinence, neither ULS nor SSLF was significa

212 n may offer new avenues for the treatment of urinary incontinence of central origin.

213 One primary end point was urinary incontinence or treatment for this condition at

214 At 3 months, the rate of urinary incontinence (or treatment) was 23.6% in the sli

215 tocele (OR, 4.9; 95% CI, 1.3-19), and stress urinary incontinence (OR, 3.1; 95% CI, 1.4-6.5), but not

216 ailure (symptomatic orthostatic hypotension, urinary incontinence, or both) at diagnosis (n=62) had a

217 bstantial number of epidemiologic studies of urinary incontinence over the past two decades, relative

218 Stress urinary incontinence, overflow incontinence and detrusor

219 generation has shown promise in adult stress urinary incontinence patients, but its applicability to

220 nce who had five or more episodes of urgency urinary incontinence per 3-day period, as recorded in a

221 on from baseline in mean episodes of urgency urinary incontinence per day over the 6-month period, as

222 The mean reduction in episodes of urgency urinary incontinence per day over the course of 6 months

223 Randomized trials in women with mixed urinary incontinence populations are needed.

224 omen with uncomplicated, demonstrable stress urinary incontinence, preoperative office evaluation alo

225 t, are less dramatic than those reported for urinary incontinence, primarily because of constipation.

226 uccess rates' published for different stress urinary incontinence procedures.

227 nence due to overactive bladder or to stress urinary incontinence published in peer-reviewed journals

228 omes included complete resolution of urgency urinary incontinence, quality of life, use of catheters,

229 Proper diagnosis and evaluation of stress urinary incontinence remains paramount in preventing sur

230 s, we give insight into the future of stress urinary incontinence research and outcomes.

231 Urinary incontinence (score of >or=3 on a validated inco

232 anded Prostate Cancer Index Composite (EPIC) urinary incontinence scores were similar at baseline as

233 ders such as overactive bladder syndrome and urinary incontinence significantly increase with age.

234 factors in the pathophysiology of fecal and urinary incontinence so as to identify modifiable risk f

235 actors have been found to be associated with urinary incontinence, some of which are amenable to modi

236 appropriate interventions, since a change in urinary incontinence status can reflect care quality in

237 eviation (0.19) in the RN ratio, the odds of urinary incontinence status improvement or maintenance o

238 e care quality defined as the improvement of urinary incontinence status or maintenance of continent

239 There are an increasing number of urinary incontinence studies outside Europe and North Am

240 ctive parameters in the evaluation of stress urinary incontinence, such as questionnaires, pad test,

241 logy in a preclinical canine model of stress urinary incontinence (SUI) and no measurable functional

242 etic slings for the treatment of male stress urinary incontinence (SUI) has increased over the last d

243 elvic organ prolapse (POP) repair and stress urinary incontinence (SUI) to augment and strengthen wea

244 Stress urinary incontinence (SUI) with more than 1 symptom or i

245 ncluding pelvic organ prolapse (POP), stress urinary incontinence (SUI), urge urinary incontinence (U

246 ent evidence for the genetic basis of stress urinary incontinence (SUI).

247 OP) surgery in women who present with stress urinary incontinence (SUI).

248 common surgical treatment for female stress urinary incontinence (SUI).

249 ts from randomized trials focusing on stress urinary incontinence surgery in older women are needed.

250 review recently published studies on stress urinary incontinence surgery outcomes in older women.

251 ical prostatectomy was associated with worse urinary incontinence than EBRT (-18.0 points; 95% CI, -2

252 th a greater decrease in sexual function and urinary incontinence than either EBRT or active surveill

253 going prostatectomy were more likely to have urinary incontinence than were those undergoing radiothe

254 table urinary incontinence can be applied to urinary incontinence that cannot be managed using conven

255 n, a significant portion of whom report urge urinary incontinence that is inadequately treated with f

256 serious neurologic disease) associated with urinary incontinence, the clinician should initiate unsu

257 For urinary incontinence, the greatest need is to compare ph

258 Urinary incontinence, the involuntary loss of urine, is

259 High-quality, level 1 evidence for urinary incontinence therapy can guide clinicians in the

260 s of care have not changed significantly for urinary incontinence, there have been recent advances wi

261 erence "Advancing the Treatment of Fecal and Urinary Incontinence Through Research" had as one of its

262 omen with uncomplicated, demonstrable stress urinary incontinence to compare outcomes after preoperat

263 The Urinary Incontinence Treatment Network and Pelvic Floor

264 is lacking regarding the treatment of mixed urinary incontinence, treatment generally begins with co

265 levance: Among women with refractory urgency urinary incontinence, treatment with onabotulinumtoxinA

266 testing enhances surgical outcome of stress urinary incontinence treatments by improving case select

267 Urinary incontinence treatments yield high levels of pat

268 Urinary incontinence (UI) affects between 40 and 60% of

269 aged 18 or over with a diagnosis of stroke; urinary incontinence (UI) as defined by the Internationa

270 Urinary incontinence (UI) in women adversely affects qua

271 ht loss involving diet modification improves urinary incontinence (UI) in women, but little is known

272 mmendations on the nonsurgical management of urinary incontinence (UI) in women.

273 Although pregnancy is a risk factor for urinary incontinence (UI), the extent of UI in nulligrav

274 ith severe dysfunctional urination including urinary incontinence (UI).

275 Women without stress urinary incontinence undergoing vaginal surgery for pelv

276 OP), stress urinary incontinence (SUI), urge urinary incontinence (UUI), and hernias, are not well un

277 Common issues for these patients include urinary incontinence, vaginal stenosis, clitoral pain, a

278 rate ratio for pharmacological treatment of urinary incontinence was 2.2 (1.4-3.7) for both genders,

279 e adjusted rate ratio for first diagnosis of urinary incontinence was 3.2 (2.7-3.7) in men and 2.7 (2

280 th active surveillance at 3 months, worsened urinary incontinence was associated with radical prostat

281 reat both apical vaginal prolapse and stress urinary incontinence was conducted between 2008 and 2013

282 cant between-group difference in the odds of urinary incontinence was noted at 15 years.

283 After prostatectomy, urinary incontinence was observed, but urinary irritatio

284 Complete resolution of urgency urinary incontinence was reported by 13% and 27% of the

285 In one major survey, urinary incontinence was the greatest risk factor for de

286 heart failure, coronary artery disease, and urinary incontinence were associated with an increased r

287 All 38 men with no baseline urinary incontinence were leak-free and pad-free by 9 mo

288 , diagnosis, results, and treatment of mixed urinary incontinence were selected for review.

289 e-control study, urinary catheterization and urinary incontinence were the only factors associated wi

290 nce abuse, pain (spinal and peripheral), and urinary incontinence, whereas NOP antagonists have been

291 rial involving women with idiopathic urgency urinary incontinence who had five or more episodes of ur

292 ine the prevalence and etiology of fecal and urinary incontinence will need to first define these con

293 ropubic urethropexies, and for managing urge urinary incontinence with anticholinergic medications.

294 level 1 evidence in the management of stress urinary incontinence with multicentric randomized contro

295 high-quality (level 1) evidence for treating urinary incontinence with weight loss, for treating stre

296 0.11 [CI, 0.07 to 0.14]) but did not resolve urinary incontinence, with no significant dose-response

297 A review of the diagnosis of male urinary incontinence, with particular reference to studi

298 role of preoperative urodynamics for stress urinary incontinence, with particular reference to the c

299 Anticholinergic drugs resolved urinary incontinence, with similar effects from oxybutyn

300 77% of women residing in nursing homes have urinary incontinence, yet only 25% seek or receive treat